Here, we found that OLR1 was significantly overexpressed in CAFs of lung cancer and was associated with adverse patient outcomes, and OLR1+ CAFs promote the growth of lung cancer cells in vitro and in vivo, as well as immune evasion. Here, OLR1 is linked to lung carcinoma.